ainer
PVC/PVDC blisters. One blister contains 7, 10 or 14 film-coated tablets.
Pack sizes: 7, 14, 28, 30, 56, 90, 98 or 280 film-coated tablets and multipacks containing 280 (4x70 or 20x14) film-coated tablets.
PVC/PVDC perforated unit dose blisters. One blister contains 7, 10 or 14 film-coated tablets.
Pack sizes: 56, 98 or 280 film-coated tablets.
Not all pack sizes may be marketed.
6.6 Special precautions for disposal and other handling
No special requirements.
7. MARKETING AUTHORISATION HOLDER
Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom
8. MARKETING AUTHORISATION NUMBER(S)
EU/1/06/370/001
EU/1/06/370/002
EU/1/06/370/003
EU/1/06/370/004
EU/1/06/370/005
EU/1/06/370/006
EU/1/06/370/007
EU/1/06/370/008
EU/1/06/370/025
EU/1/06/370/026
EU/1/06/370/027
EU/1/06/370/034
EU/1/06/370/037
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Date of first authorisation: 17.01.2007
Date of latest renewal: 22.11.2011
10. DATE OF REVISION OF THE TEXT
22.11.2011
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu
|
